Methods Of Use And Compositions For The Diagnosis And Treatment Of Infectious Disease
US Application 60/381,220
Filed on 2002-05-17
Filed on 2002-05-17
Use Ixolaris, A Tissue Factor (Anticoagulant) Inhibitor, For The Treatment Of Cancer
US Application 61/225,961
Filed on 2009-07-16
Filed on 2009-07-16
GARP (LRRC32) is Essential for the Surface Expression of Latent TGF-B
US Application 61/185,933
Filed on 2009-06-10
Filed on 2009-06-10
Reprogramming Of Somatic Cells By BORIS Gene
US Application 61/248,286
Filed on 2009-10-02
Filed on 2009-10-02
Discovery Of Novel Pharmacophores Inhibiting The Growth Of Mycobacterium Tuberculosis
US Application 61/162,588
Filed on 2009-03-23
Filed on 2009-03-23
Use Of Ixolaris, A Tissue Factor (anticoagulant) Inhibitor, For The Treatment Of Cancer
US Application 61/161,223
Filed on 2009-03-18
Filed on 2009-03-18
Live Vaccine Strains of Francisella Tularensis with Defined Mutations: Composition and Method of Use
US Application 61/156,173
Filed on 2009-02-27
Filed on 2009-02-27
Influenza Hemagglutinin And Neuraminidase Variants
US Application 61/152,094
Filed on 2009-02-12
Filed on 2009-02-12
CD121a (IL-1 Receptor Type 1) On Activated Human FOXP3+ Regulatory T Cells
US Application 61/155,430
Filed on 2009-02-25
Filed on 2009-02-25
Method And Medium For Host Cell-free (axenic) Growth Of Coxiella Burnetiia
US Application 61/154,330
Filed on 2009-02-20
Filed on 2009-02-20